Upcoming webinars
1-4 of 7

PCSS - Systemic Review of MAUD
DATE: Thursday, January 30, 9:00 - 10:00 am
Join Dr. Melissa Weimer for a presentation on medications for alcohol use disorder (MAUD).

ED Treatment of OUD
DATE: Thursday, February 6, 9:00-10:00 am
In this presentation, Gail D’Onofrio, MD, MS will discuss the evidence regarding initiation of buprenorphine in the ED, describe innovations in dosing and formulations (extended-release and high dose initiation), and discuss implementation strategies to improve uptake of evidence-based practices

MOUD in Pregnancy
DATE: Wednesday, February 5, 12:00 - 1:30 pm
This interactive webinar, facilitated by Mark Duncan, MD and Maureen Oscadal, MPH, RN, BSN, CARN, explores emerging practices in the care of patients with opioid use disorder during the perinatal period and will feature a brief presentation, facilitated expert discussion, and Q&A.

What’s the Latest? WA State Drug Trends
DATE: Wednesday, March 12, 12:00 - 1:00 pm
Dr. Caleb Banta-Green, an epidemiologist at the University of Washington, will focus on emerging drug trends in WA State, and the implications of recent mortality and drug checking data for MOUD patients and providers.

Improved Outcomes in Precipitated Withdrawal
DATE: Wednesday, May 7, 12:00 - 1:30 pm
This interactive webinar, facilitated by Mark Duncan, MD and Maureen Oscadal, MPH, RN, BSN, CARN, explores pathways to improved outcomes for precipitated withdrawal in patients with opioid use disorder who use fentanyl and other high potency synthetic opioids.

Breaking Barriers to Methadone
DATE: Wednesday, August 6, 12:00 - 1:30 pm
This webinar, facilitated by Mark Duncan, MD and Maureen Oscadal, MPH, RN, BSN, CARN, will provide updates on access and approaches to methadone treatment with a brief presentation, expert discussion, and Q+A session.

When Patients Want to Taper Off MOUD
DATE: Wednesday, November 5, 12:00-1:30 pm
This interactive webinar, facilitated by Mark Duncan, MD and Maureen Oscadal, MPH, RN, BSN, CARN, discusses key conversations and considerations for the care of people who want to taper off MOUD. A brief presentation will be followed by expert discussion and Q+A sessions.
Upcoming learning series
1-4 of 4

Substance Use Disorders in Hospital Care ECHO
DATE: 12 sessions. Wednesdays, 12:00 - 1:00 p.m. April 2 - June 18
Region 10 / OHSU ECHO series to build or improve care systems to effectively treat addiction in a hospital setting. Format includes didactic presentations, case reviews, and interactive discussions.

Undoing Stigma in SUD Care
DATE: Thursdays, 10:00 - 11:00 am, February 6-27
This 4-part series will explore the impact of stigma on individuals living with substance use disorder, their concerned significant others, and healthcare providers. Each session will focus on different aspects of stigma, examining its harmful effects and providing strategies to address bias.

Quarterly Emergency Department Call
DATE: Fourth Tuesday, 9:00 - 10:00 am, January - October
Chris Buresh, MD, MPH, DTM&H, and Wendy Williams-Gilbert, PhD, RN, CARN, ANPD-BC facilitate conversations on how to implement and sustain MOUD programs in the ED. Call participants are invited to share best practices and lessons learned to support patients with opioid use disorder.

Substance Use Disorders in EDs ECHO
DATE: 11 sessions. Thursdays, 12:00 - 1:00 p.m., February 11 - May 6
Region 10 / OHSU ECHO series to improve services provided to people with substance use disorder accessing emergency departments for care. Format includes didactic presentations, case reviews, and interactive discussions.
Recorded trainings
1-4 of 5

UW PCL Medications for Opioid Use Disorder Part 3…
Dr. Buchholz, MD applies knowledge learned in parts 1 and 2 to clinical cases, highlighting key clinical considerations for initiation of MOUD.

UW PCL Medications for Opioid Use Disorder Part 2…
Dr. Buchholz, MD takes us through FDA approved medications for opioid use disorder, including multiple strategies for initiating buprenorphine in various treatment settings and clinical scenarios.

UW PCL Medications for Opioid Use Disorder Part 1…
Dr. Buchholz, MD reviews current Washington State overdose data, highlighting the prominence of fentanyl as a leading cause of death, a more detailed description of opioid neurobiology, and assessment strategies for OUD.

Opioid Use Disorder: A Treatable Medical Condition
Guest lecturer Dr. Alexis LaPietra, DO, FACEP lays out the science behind treating OUD as you would any other medical condition.

Opioid Use Disorder in Adolescents
Guest lecturer Dr. Chris Buresh, MD, MPH discusses how to initiate MOUD with adolescent patients.